Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators

Journal of Cardiac Failure

Volumn 18, Issue 7, 2012, Pages 556-563

  Daidoji, Hyuma ^a   Arimoto, Takanori ^a   Nitobe, Joji ^a   Tamura, Harutoshi ^a   Kutsuzawa, Daisuke ^a   Ishigaki, Daisuke ^a   Ishino, Mitsunori ^a   Takahashi, Hiroki ^a   Shishido, Tetsuro ^a   Miyashita, Takehiko ^a   Miyamoto, Takuya ^a   Watanabe, Tetsu ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

heart type fatty acid binding protein; Implantable cardioverter defibrillator; ongoing myocardial damage; prognosis; troponin T

Indexed keywords

AMIODARONE; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOMYOPATHY; CLINICAL FEATURE; CONTROLLED STUDY; DEFIBRILLATOR; EVENT FREE SURVIVAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DEATH; HEART FAILURE; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE INJURY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMPLANTATION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SHOCK; SINUS TACHYCARDIA; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; TROPONIN T;

EID: 84862976123     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.04.006     Document Type: Article

References (23)

1. J.P. Piccini, S.M. Al-Khatib, E.R. Myers, K.J. Anstrom, A.E. Buxton, and E.D. Peterson Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis J Cardiovasc Electrophysiol 21 2010 791 798
2. G.D. Sanders, M.A. Hlatky, and D.K. Owens Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med 353 2005 1471 1480 (Pubitemid 41400921)
3. J. Irvine, P. Dorian, B. Baker, B.J. O'Brien, R. Roberts, and M. Gent Quality of life in the Canadian Implantable Defibrillator Study (CIDS) Am Heart J 144 2002 282 289 (Pubitemid 34879652)
4. J.E. Poole, G.W. Johnson, A.S. Hellkamp, J. Anderson, D.J. Callans, and M.H. Raitt Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
5. G. Olivetti, R. Abbi, F. Quaini, J. Kajstura, W. Cheng, and J.A. Nitahara Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
6. P. Anversa, and J. Kajsture Myocyte cell death in the diseased heart Circ Res 82 1998 1231 1233 (Pubitemid 28311130)
7. S. Kostin, L. Pool, A. Elsässer, S. Hein, H.C. Drexler, and E. Arnon Myocytes die by multiple mechanisms in failing human hearts Circ Res 92 2003 715 724 (Pubitemid 36457635)
8. T. Niizeki, Y. Takeishi, T. Arimoto, N. Takabatake, N. Nozaki, and O. Hirono Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients J Card Fail 13 2007 120 127 (Pubitemid 46467389)
9. A.F. Sonel, A. Shalaby, J.P. McConnell, T. Czarnecki, S. Hogen, and M. Zahid Detectable troponin levels predict poor prognosis in patients with left ventricular dysfunction undergoing internal defibrillator implantation Pacing Clin Electrophysiol 30 2007 839 844 (Pubitemid 46955403)
10. T. Niizeki, Y. Takeishi, T. Arimoto, T. Takahashi, H. Okuyama, and N. Takabatake Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure Circ J 69 2005 922 927 (Pubitemid 41124259)
11. T. Arimoto, Y. Takeishi, T. Niizeki, N. Nozaki, O. Hirono, and T. Watanabe Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure J Card Fail 13 2007 34 41 (Pubitemid 46330832)
12. C.J. McCann, B.M. Glover, I.B. Menown, M.J. Moore, J. McEneny, and C.G. Owens Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T Eur Heart J 29 2008 2843 2850
13. G. Haltern, S. Peiniger, A. Bufe, G. Reiss, H. Gülker, and T. Scheffold Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction Am J Cardiol 105 2010 1 9
14. K. Viswanathan, N. Kilcullen, C. Morrell, S.J. Thistlethwaite, M.U. Sivananthan, and T.B. Hassan Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative J Am Coll Cardiol 55 2010 2590 2598
15. G. Gregoratos, J. Abrams, A.E. Epstein, R.A. Freedman, D.L. Hayes, and M.A. Hlatky American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation 106 2002 2145 2161 (Pubitemid 35192824)
16. G.H. van Welsenes, J.B. van Rees, C.J. Borleffs, S.C. Cannegieter, J.J. Bax, L. van Erven, and M.J. Schalij Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients Europace 13 2011 389 394
17. E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A.S. Jaffe, and H.A. Katus Analytical validation of a high-sensitivity cardiac troponin T assay Clin Chem 56 2010 254 261
18. T. Arimoto, Y. Takeishi, T. Niizeki, Y. Koyama, H. Okuyama, and N. Nozaki Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure Ann Nucl Med 19 2005 535 540 (Pubitemid 43161837)
19. S.H. Hohnloser, K.H. Kuck, P. Dorian, R.S. Roberts, J.R. Hampton, and R. Hatala DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488 (Pubitemid 39603155)
20. X. Meng, M. Ming, and E. Wang Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage Forensic Sci Int 160 2006 11 16 (Pubitemid 43928397)
21. A. Verma, F. Kilicaslan, D.O. Martin, S. Minor, R. Starling, and N.F. Marrouche Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies Heart 92 2006 190 195 (Pubitemid 43131958)
22. M. Christ, J. Sharkova, S. Bayrakcioglu, I. Herzum, C. Mueller, and W. Grimm B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators Eur J Heart Fail 9 2007 272 279 (Pubitemid 46343709)
23. V.Y. Reddy, M.R. Reynolds, P. Neuzil, A.W. Richardson, M. Taborsky, and K. Jongnarangsin Prophylactic catheter ablation for the prevention of defibrillator therapy N Engl J Med 357 2007 2657 2665